1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges,
Trends
4. Voice of Customer
5.
Global
Companion Diagnostic Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product and Services (Kits and Reagents,
Assays, Software, and Services)
5.2.2. By Technology (PCR, NGS, In-Situ
Hybridization, Immunohistochemistry, and Others)
5.2.3. By Disease Indication (Oncology, Neurology,
Cardiology, Infectious Diseases, and Others)
5.2.4. By Application (In-Vitro Diagnostics, Drug
Discovery, and Others)
5.2.5. By End User (Pharmaceutical &
Biotechnology Companies, Research Laboratories, Contract Research Organization,
and Others)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Market Map
6.
North
America Companion Diagnostic Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1.
By Product
and Services
6.2.2.
By Technology
6.2.3. By Disease Indication
6.2.4. By Application
6.2.5.
By End
User
6.2.6.
By
Country
6.3. North America: Country Analysis
6.3.1. United States Companion Diagnostic
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product
and Services
6.3.1.2.2.
By
Technology
6.3.1.2.3.
By
Disease Indication
6.3.1.2.4.
By
Application
6.3.1.2.5.
By End
User
6.3.2. Canada Companion Diagnostic
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Product and Services
6.3.2.2.2.
By
Technology
6.3.2.2.3.
By
Disease Indication
6.3.2.2.4.
By
Application
6.3.2.2.5.
By End
User
6.3.3. Mexico Companion Diagnostic
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Product and Services
6.3.3.2.2.
By
Technology
6.3.3.2.3.
By
Disease Indication
6.3.3.2.4.
By
Application
6.3.3.2.5.
By End
User
7.
Europe
Companion Diagnostic Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product and Services
7.2.2. By Technology
7.2.3. By Disease Indication
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Companion Diagnostic
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Product and Services
7.3.1.2.2.
By
Technology
7.3.1.2.3.
By
Disease Indication
7.3.1.2.4.
By
Application
7.3.1.2.5.
By End
User
7.3.2. United Kingdom Companion Diagnostic
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Product and Services
7.3.2.2.2.
By
Technology
7.3.2.2.3.
By
Disease Indication
7.3.2.2.4.
By
Application
7.3.2.2.5.
By End
User
7.3.3. Italy Companion Diagnostic
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By
Product and Services
7.3.3.2.2.
By
Technology
7.3.3.2.3.
By
Disease Indication
7.3.3.2.4.
By
Application
7.3.3.2.5.
By End
User
7.3.4. France Companion Diagnostic
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Product and Services
7.3.4.2.2.
By
Technology
7.3.4.2.3.
By
Disease Indication
7.3.4.2.4.
By
Application
7.3.4.2.5.
By End
User
7.3.5. Spain Companion Diagnostic
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Product and Services
7.3.5.2.2.
By
Technology
7.3.5.2.3.
By
Disease Indication
7.3.5.2.4.
By
Application
7.3.5.2.5.
By End
User
8.
Asia-Pacific
Companion Diagnostic Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product and Services
8.2.2. By Technology
8.2.3. By Disease Indication
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Companion Diagnostic
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By
Product and Services
8.3.1.2.2.
By
Technology
8.3.1.2.3.
By
Disease Indication
8.3.1.2.4.
By
Application
8.3.1.2.5.
By End
User
8.3.2. India Companion Diagnostic
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Product and Services
8.3.2.2.2.
By
Technology
8.3.2.2.3.
By
Disease Indication
8.3.2.2.4.
By
Application
8.3.2.2.5.
By End
User
8.3.3. Japan Companion Diagnostic
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Product and Services
8.3.3.2.2.
By
Technology
8.3.3.2.3.
By
Disease Indication
8.3.3.2.4.
By
Application
8.3.3.2.5.
By End
User
8.3.4. South Korea Companion Diagnostic
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By
Product and Services
8.3.4.2.2.
By
Technology
8.3.4.2.3.
By
Disease Indication
8.3.4.2.4.
By
Application
8.3.4.2.5.
By End
User
8.3.5. Australia Companion Diagnostic
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By
Product and Services
8.3.5.2.2.
By
Technology
8.3.5.2.3.
By
Disease Indication
8.3.5.2.4.
By
Application
8.3.5.2.5.
By End
User
9.
South
America Companion Diagnostic Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product and Services
9.2.2. By Technology
9.2.3. By Disease Indication
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Companion Diagnostic
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Product and Services
9.3.1.2.2.
By
Technology
9.3.1.2.3.
By
Disease Indication
9.3.1.2.4.
By
Application
9.3.1.2.5.
By End
User
9.3.2. Argentina Companion Diagnostic
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Product and Services
9.3.2.2.2.
By
Technology
9.3.2.2.3.
By
Disease Indication
9.3.2.2.4.
By
Application
9.3.2.2.5.
By End
User
9.3.3. Colombia Companion Diagnostic
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Product and Services
9.3.3.2.2.
By
Technology
9.3.3.2.3.
By
Disease Indication
9.3.3.2.4.
By
Application
9.3.3.2.5.
By End
User
10. Middle East and Africa Companion Diagnostic
Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product and Services
10.2.2. By Technology
10.2.3. By Disease Indication
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Companion Diagnostic
Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By
Product and Services
10.3.1.2.2.
By
Technology
10.3.1.2.3.
By
Disease Indication
10.3.1.2.4.
By
Application
10.3.1.2.5.
By End
User
10.3.2. Saudi Arabia Companion Diagnostic
Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By
Product and Services
10.3.2.2.2.
By
Technology
10.3.2.2.3.
By
Disease Indication
10.3.2.2.4.
By
Application
10.3.2.2.5.
By End
User
10.3.3. UAE Companion Diagnostic Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By
Product and Services
10.3.3.2.2.
By
Technology
10.3.3.2.3.
By
Disease Indication
10.3.3.2.4.
By
Application
10.3.3.2.5.
By End
User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Companion Diagnostic Market: SWOT
Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
15.5.1.
Abbott Laboratories Inc.
15.5.2.
Agilent Technologies Inc.
15.5.3.
F.Hoffmann-La Roche Ltd
15.5.4.
Biomerieux SA
15.5.5.
Qiagen NV
15.5.6.
Siemens Healthcare
15.5.7.
Thermo Fisher Scientific Inc.
15.5.8.
Danaher Corporation (Beckman Coulter Inc.)
15.5.9.
Myriad Genetics Inc.
15.5.10.
Illumina Inc.
16. Strategic Recommendations
17. About Us &
Disclaime